13.17
Vor Biopharma Inc (VOR) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
-
|
- | - | - | - |
|
|
89.75%
28.11
|
274.28 | 33.29 | 31.31 | 28.51 |
| Operating Income/Loss |
89.75%
-28.11
|
-274.28 | -33.29 | -31.31 | -28.51 |
| Nonoperating Income/Loss |
39.62%
-784.58
|
-1,299.38 | 0.805 | 0.599 | 0.954 |
| Income/Loss From Continuing Operations Before Tax |
48.36%
-812.68
|
-1,573.67 | -32.49 | -30.71 | -27.56 |
| Income/Loss From Continuing Operations After Tax |
48.36%
-812.68
|
-1,573.67 | -32.49 | -30.71 | -27.56 |
|
|
48.36%
-812.68
|
-1,573.67 | -32.49 | -30.71 | -27.56 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
94.67%
6.6818
|
125.27 | 124.82 | 0.4396 | 68.47 |
| Diluted Average Shares |
94.67%
6.6818
|
125.27 | 124.82 | 0.4396 | 68.47 |
| Basic Earnings Per Share |
868.39%
-121.63
|
-12.56 | -0.26 | -0.44 | -0.40 |
| Diluted Earnings Per Share |
868.39%
-121.63
|
-12.56 | -0.26 | -0.44 | -0.40 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):